NIH-funded research NIH-funded research

SARS-CoV adaptations through a Systems Biology Lens (SYBIL) in humans and animal models

Official title: SARS-CoV adaptations through a Systems Biology Lens (SYBIL)

Funded at Icahn School of Medicine at Mount Sinai · NIH-11533180 · Data updated 2026-11-12

A team at Mount Sinai is studying how SARS-CoV-2 affects the body by mapping host-virus networks and blood biomarkers to identify new targets for therapy.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai
NIH-funded
Lab location1 site (New York, United States)
Project startJanuary 20, 2018
Project endDecember 31, 2027
Funding year2026
Award (this year)$48,710
NIH project number3U19AI135972-09S1
Project IDNIH-11533180 on NIH RePORTER

Who could benefit from this research

Could help

Individuals with or at risk for SARS-CoV-2 infection or related coronaviruses, plus researchers using patient-derived data and samples,

Less likely to help

Healthy individuals or patients without coronavirus infection are unlikely to directly benefit.

What this research studies

This project uses systems biology and omics data to understand how SARS-CoV-2 interacts with human biology and how host responses influence disease severity. Researchers will combine modeling, machine learning, and bioinformatics to pinpoint networks and blood markers tied to infection outcomes. The work builds on prior influenza studies and now extends to SARS-CoV-2 with a focus on host adaptation and early response, including the bat-to-human transition. Findings could reveal new therapeutic targets and guide precision approaches for treating COVID-19 and related coronaviruses.

Why it matters

Potential benefit: If successful, patients could benefit from new therapeutic targets and strategies to improve outcomes in SARS-CoV-2 infection and related coronaviruses.

How similar studies have gone: Prior systems biology work on influenza informed the SARS-CoV-2 shift, with identification of host networks and biomarkers guiding potential interventions.

Where this research is happening

  • Icahn School of Medicine at Mount Sinai
    New York, United States
    Active

Researchers

  • Principal investigator: Garcia-Sastre, Adolfo — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Garcia-Sastre, Adolfo

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.